Regeneron Renews Sponsorship of the Regeneron Science Talent Search Through 2036, Committing an Additional $150 Million to Empower the Next Generation of Science and Technology Leaders
MWN-AI** Summary
Regeneron Pharmaceuticals, Inc. has extended its title sponsorship of the Regeneron Science Talent Search (STS) for another decade, committing an additional $150 million to support the U.S.'s oldest and most prestigious science and mathematics competition for high school seniors. Since Regeneron began its sponsorship in 2017, it has engaged over 20,000 young scientists, recognized 3,000 individuals as Regeneron Scholars, and awarded more than $31 million in prizes. The renewed investment raises Regeneron’s total funding for STS and the Regeneron International Science and Engineering Fair (ISEF) to over $300 million from 2017 to 2036.
George D. Yancopoulos, co-founder and Chief Scientific Officer of Regeneron, highlighted the impact STS had on his own scientific journey, underscoring the importance of nurturing young talent in transforming the future of science. Regeneron’s CEO, Leonard Schleifer, emphasized the company's deep belief in science and commitment to cultivating the skills of young scientists that will drive future innovations.
Established in 1942, STS has become a key platform for high school students to present original research across various fields, such as artificial intelligence and climate science. The competition has experienced a 49% increase in entries since Regeneron became the title sponsor, reflecting its expanding reach and influence.
Moreover, Regeneron’s support extends to STEM Outreach Programs, aiming to provide quality education and resources to students from diverse backgrounds. The initiative is a part of Regeneron's larger commitment, termed STEM-Fueled™, focused on empowering the next generation of scientific pioneers to address pressing global challenges.
MWN-AI** Analysis
Regeneron Pharmaceuticals' recent announcement to renew its sponsorship of the Regeneron Science Talent Search (STS) through 2036—coupled with an additional commitment of $150 million—demonstrates a strategic investment not only in STEM outreach but also in the biotech company’s long-term growth and reputational capital. This dramatic increase in funding emphasizes Regeneron's commitment to developing future leaders in science and technology, potentially leading to breakthroughs that could translate into transformative therapies.
With this extension, Regeneron’s collective investment in STS and the Regeneron International Science and Engineering Fair (ISEF) will surpass $300 million, showcasing the company's focus on nurturing talent and innovation. This move serves as an attractive marketing strategy to bolster public perception and reinforce Regeneron's position as a leader in biopharmaceuticals—an aspect that can resonate positively with investors who prioritize socially responsible and community-engaged companies.
For investors, this commitment portends a dual benefit: an immediate improvement in community relations and potential long-term viability of future drug developments from emerging scientists who may contribute to groundbreaking research. Historically, participants in STS have gone on to achieve significant accomplishments, including Nobel Prizes and major scientific advancements. This indicates a direct correlation between Regeneron’s philanthropic investment and potential future returns in innovation and intellectual capital.
Moreover, a 49% increase in entries to STS since Regeneron became the title sponsor signals growing interest in STEM fields, which could lead to a larger talent pool for the biotechnology sector. Investors should closely monitor Regeneron's endeavors in STEM programs as they reinforce its commitment to an evolving scientific landscape and recognize the importance of diversifying and investing in human capital.
Overall, this strategy positions Regeneron favorably within the biotech industry and could enhance stock performance as it attracts a new generation of innovators essential for its future growth.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Key Takeaways:
- Regeneron will extend its title sponsorship of the Regeneron Science Talent Search (STS) for a second decade, continuing its partnership with Society for Science to support the United States’ oldest and most prestigious science and mathematics competition for high school seniors
- Since the start of Regeneron’s sponsorship in 2017 through this year’s STS, Regeneron and the Society have engaged and inspired more than 20,000 of the nation’s top young scientists, recognized 3,000 as Regeneron scholars, and awarded over $31 million in prizes
- Regeneron is also the title sponsor of the Regeneron International Science and Engineering Fair (ISEF), a program of Society for Science and the world’s largest high school science competition
- Today’s commitment brings Regeneron’s total STS and ISEF investment, from 2017 to 2036, to more than $300 million
TARRYTOWN, N.Y. and WASHINGTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced the renewal of Regeneron’s title sponsorship of the Regeneron Science Talent Search (STS), the United States’ oldest and most prestigious science and mathematics competition for high school seniors. The company is increasing its commitment for the next 10 years by 50%, pledging an additional $150 million to further empower and inspire the next generation of science and technology leaders, and bringing its 20-year investment in STS to $250 million. Regeneron is also the title sponsor of the Regeneron International Science and Engineering Fair (ISEF), a program of the Society and the world’s largest high school science competition. Regeneron’s support for these two premier programs totals more than $300 million from 2017 to 2036.
“My own scientific journey can be traced back to my experience with the Science Talent Search, which profoundly shaped who I am today. Participating in and becoming a winner of STS gave me the confidence to dedicate my life to science and the pursuit of inventing medicines that improve people’s lives,” said George D. Yancopoulos, M.D., Ph.D., co-Founder, co-Chairman, President, and Chief Scientific Officer at Regeneron, and a 1976 STS Winner. “Today, Regeneron helps millions of people around the world facing serious diseases, which is a testament to what is possible when young scientific talent is nurtured. We are renewing our commitment to STS because we see in these students that same potential to transform our world, and we eagerly await their future contributions to science and humanity.”
“At Regeneron, our success has always been driven by a deep belief in science and the people behind it,” said Leonard S. Schleifer, M.D., Ph.D., co-Founder, co-Chairman, President, and Chief Executive Officer at Regeneron, and 1970 STS Alumnus. “This renewed, long-term investment in the Regeneron Science Talent Search – alongside our support for many other STEM education programs – reflects our confidence in the extraordinary potential of young scientists and our responsibility to help cultivate the curiosity, rigor and leadership that will shape the future of scientific discovery.”
What is the Regeneron Science Talent Search?
The Regeneron Science Talent Search, first established in 1942 as the Westinghouse Science Talent Search and later the Intel Science Talent Search, is now proudly supported by Regeneron as its third long-term sponsor. Since the beginning of this enduring sponsorship through this year’s STS, Regeneron and the Society have engaged and inspired more than 20,000 of the nation’s top young scientists, recognized 3,000 as Regeneron scholars, and awarded over $31 million in prizes.
For 85 years, STS has recognized and championed the United States’ most promising young scientists whose groundbreaking research and leadership potential can fuel the breakthroughs of tomorrow. The competition serves as a catalyst for young scientists to build confidence, strengthen their research skills, and deepen their commitment to high-quality scientific inquiry.
“In its 85th year, the Science Talent Search inspires and elevates the nation’s top high school students passionate about tackling the world’s most intractable problems,” said Maya Ajmera, President and CEO at Society for Science; Executive Publisher, Science News; and 1985 STS Alumna. “This renewal not only secures the legacy of this historic competition but also amplifies its impact in the years ahead. With Regeneron’s unwavering support, we will continue to empower the extraordinary – the rising stars and the legends in the making – who will define the future of science, innovation, and discovery.”
Each year, nearly 2,500 of the nation’s top science and math students from across the United States enter STS, presenting original research spanning fields such as artificial intelligence, climate science, cancer biology, and renewable energy. Thousands of STS alumni have gone on to world-changing careers in science, with several earning esteemed honors, including the Nobel Prize, the Fields Medal, the National Medal of Science, and the MacArthur Fellowship for groundbreaking research across STEM fields. Since Regeneron became the title sponsor, entries to STS have increased by 49%, reflecting a significant expansion in the program’s reach and impact on young scientists nationwide.
As part of this sponsorship renewal, Regeneron will continue to support the Society's STEM Outreach Programs. Through these programs, the Society works to provide high-quality educator training and reach young people across the country – in every state, including both urban and rural areas, and regardless of socioeconomic status, gender, or race – to help all students reach their full potential through STEM.
Regeneron’s STS and ISEF sponsorships are a cornerstone of STEM-Fueled™, the company’s collection of longstanding programs and partnerships that fuel the next generation of scientific innovators to pursue bold ideas and advance world-changing solutions. Through philanthropic investments, Regeneron has provided more than 4 million students with STEM experiences since 2020.
What is Regeneron?
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops, and commercializes potentially life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic conditions, infectious diseases, and rare diseases.
Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity and excellence, and to build sustainable communities. Our most significant philanthropic investments are in science education, a commitment we call STEM-Fueled™ – our collection of programs and partnerships, including the Regeneron Science Talent Search (STS) and the Regeneron International Science and Engineering Fair (ISEF), that fuel future scientific innovators to pursue bold ideas and advance world-changing solutions. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro bono, and matching gift programs. We are proud to be recognized on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the United States.
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.
What is Society for Science?
Society for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair, and the Thermo Fisher Scientific Junior Innovators Challenge, and its STEM Outreach programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate, and inspire. Learn more at www.societyforscience.org and follow us on Facebook, X, Instagram, and LinkedIn.
Media Contacts:
Tina Parisi Tuttle, Regeneron
914-847-3511, tinaparisituttle@regeneron.com
Gayle Kansagor, Society for Science
703-489-1131, gkansagor@societyforscience.org
FAQ**
How does Regeneron Pharmaceuticals Inc. REGN plan to utilize the additional $150 million commitment over the next years to enhance the impact of the Regeneron Science Talent Search (STS)?
What specific metrics will Regeneron Pharmaceuticals Inc. REGN use to measure the success of its investment in the Regeneron Science Talent Search and the International Science and Engineering Fair (ISEF)?
Can you elaborate on how Regeneron Pharmaceuticals Inc. REGN’s partnership with the Society for Science influences the development of future scientific leaders through the STS?
What strategies does Regeneron Pharmaceuticals Inc. REGN have in place to ensure that its STEM Outreach Programs reach diverse groups, including underserved populations, to maximize the impact of its investment?
**MWN-AI FAQ is based on asking OpenAI questions about Regeneron Pharmaceuticals Inc. (NASDAQ: REGN).
NASDAQ: REGN
REGN Trading
-1.59% G/L:
$742.885 Last:
150,713 Volume:
$754.55 Open:
